by Jordana Choucair | Mar 15, 2022 | Life Sciences
Biogen Inc. will gain full authority over Aduhelm, its controversial Alzheimer’s disease drug, after partner Eisai Co. gave up its rights to make regulatory or sales decisions and share in the profits for the treatment. The drug’s outlook has weakened...
by Jordana Choucair | Mar 15, 2022 | M&A
Clarify Health, a leading cloud analytics and value-based payments platform, announced it will acquire Embedded Healthcare in an effort to enhance its value-based care offerings. Clarify Health will leverage Embedded Healthcare’s behavioral science tools, providing...
by Jordana Choucair | Mar 15, 2022 | Mental Health
A study published in JAMA Pediatrics found that the pandemic took a large toll on children’s mental health and overall household stability, but several of these trends had been building for years. Levels of anxiety and depression among children increased between...
by Jordana Choucair | Mar 15, 2022 | Opioid/Substance Use Disorders
The House Oversight and Reform Committee asked the Justice and Treasury departments to review tax deductions claimed by four drug companies that agreed to a $26 billion settlement to end lawsuits tied to the opioid crisis. Lawmakers said the companies may be trying to...
by Jordana Choucair | Mar 15, 2022 | Providers
The Department of Veterans Affairs (VA) released a report indicating that it plans to close several medical centers and community-based clinics. The VA proposed closing medical centers in Massachusetts, New York, and Ohio along with dozens of community-based clinics...
by Jordana Choucair | Mar 14, 2022 | Life Sciences
Pfizer CEO Albert Bourla said on Sunday that a fourth dose of the COVID-19 vaccine will be necessary to continue to help keep hospitalizations manageable and sicknesses milder. He said Pfizer plans to submit data for a fourth COVID-19 dose, and then see what...
Recent Comments